Delivery Order SPE2DB22D9304-SPE2DB24FSSN6
Award Date 3/8/24
Potential Completion Date 3/29/24
Potential Value $7.7K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $3,094.80 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The order is for the delivery of XOLAIR 150 MG/ML syringes, with a period of performance ending on July 17, 2024. The award is issued under DMS Pharmaceutical Group's $499,999,999 indefinite delivery contract (IDC) with the DLA, which allows the agency to place delivery orders for a comprehensive range of...
- This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $77,370.00 firm fixed-price delivery order is for the supply of XOLAIR 150 MG/ML syringes. This award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which covers a comprehensive range of pharmaceutical products to support the medical supply...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The order is for the supply of Xolair 150 mg/mL syringes, with a potential value of $37,137.60 and a completion date of January 12, 2024. The delivery order is part of a larger indefinite delivery contract held by DMS Pharmaceutical Group Inc. with DLA, valued up to $5 million through December 2025, to provide a variety of pharmaceutical items...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $9,284.40 award is for the delivery of XOLAIR 150 MG/ML SYRINGEML, a specialized pharmaceutical product, with a completion date of February 7, 2025. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of XOLAIR 150 MG/ML syringes. The contract is a firm fixed-price delivery order with a ceiling value of $7,737.00 and a period of performance through April 5, 2024. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery vehicle (IDV) contract, #4600082013 under the SPE2DB program, with DLA valued at up to $4,999,999 through the end of...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract worth $3,094.80 to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract is for the delivery of XOLAIR 150 MG/ML syringes and has a performance period through May 2, 2024. This award is placed against DMS Pharmaceutical Group's existing indefinite delivery contract SPE2DB with DLA, valued at up to $4,999,999 through 2025. Under this broader contract vehicle, DMS Pharmaceutical Group...
- This is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award, valued at $30,948.00, is for the supply of XOLAIR 150 MG/ML SYRINGEML, a specialty pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at up to $499,999,999, which runs through December 31,...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award, valued at $3,094.80, is for the supply of XOLAIR 150 MG/ML syringes. This order is placed under DMS Pharmaceutical Group's existing indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which runs through December 31, 2025. The IDC allows the DLA to...
- This is a firm fixed-price delivery order award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA) under the SPE2DB program. The award, valued at $6,189.60, is for the supply of XOLAIR 150 MG/ML syringes. The delivery order has an ultimate completion date of August 23, 2024. This award is part of a larger indefinite delivery contract (IDC) with a ceiling value of up to $499,999,999, which allows the DLA to issue firm...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business, for the supply of XOLAIR 150 MG/ML SYRINGE. The contract is a firm fixed-price delivery order with a potential value of $27,853.20 and a completion date of February 22, 2024. This delivery order is placed against DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with DLA, contract 4600082013 under the SPE2DB program, valued at up to...